Advertisement
Research Article| Volume 45, ISSUE 7, P1168-1174, May 2009

Obtaining ‘fresh’ consent for genetic research with biological samples archived 10 years ago

Published:February 17, 2009DOI:https://doi.org/10.1016/j.ejca.2008.11.022

      Abstract

      Objective

      To obtain consent from breast cancer survivors to use residual tissue for a study on carriership of germ line mutations in the BRCA 1 and 2 genes. To investigate which consent regimen patients prefer for research with archived tissue.

      Participants

      One hundred and thirty-two patients surgically treated for breast cancer between 1995 and 1997 in the Netherlands Cancer Institute were mailed a consent form and a questionnaire.

      Results

      A consent form was obtained from 90%; 3% withheld consent for the use of archived tissue. A completed questionnaire was returned by 84%. ‘One-time general consent’ was considered to be the best procedure for consenting to research with stored tissue by 56%, 23% favoured the current ‘opt-out’ procedure; 21% did not know or had no preference.

      Conclusion

      Obtaining fresh consent for genetic research with stored tissue is possible at the cost of time and effort. Most patients give consent for research with residual tissue.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Oosterhuis J.W.
        • Coebergh J.W.
        • Van Veen E.B.
        Tumour banks: well-guarded treasures in the interest of patients.
        Nat Rev Cancer. 2003; 3: 73-77
        • van Diest P.J.
        No consent should be needed for using leftover body material for scientific purposes.
        BMJ. 2002; 325: 648-651
        • Coebergh J.W.
        • Van Veen E.B.
        • Vandenbroucke J.P.
        • van Diest P.
        • Oosterhuis W.
        One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries.
        BMJ. 2006; 332: 665
        • Furness P.
        Consent to using human tissue.
        BMJ. 2003; 327: 759-760
        • Bryant R.J.
        • Harrison R.F.
        • Start R.D.
        • et al.
        Ownership and uses of human tissue: what are the opinions of surgical in-patients?.
        J Clin Pathol. 2008; 61: 322-326
        • Wendler D.
        One-time general consent for research on biological samples.
        BMJ. 2006; 332: 544-547
        • Pentz R.D.
        • Billot L.
        • Wendler D.
        Research on stored biological samples: views of African American and White American cancer patients.
        Am J Med Genet A. 2006; 140: 733-739
        • Caulfield T.
        • Upshur R.E.
        • Daar A.
        DNA databanks and consent: a suggested policy option involving an authorization model.
        BMC Med Ethics. 2003; 4: E1
        • Helft P.R.
        • Champion V.L.
        • Eckles R.
        • Johnson C.S.
        • Meslin E.M.
        Cancer patients’ attitudes toward future research uses of stored human biological materials.
        J Empirical Res Human Res Ethics. 2007; 2: 15-22
        • Furness P.N.
        • Nicholson M.L.
        Obtaining explicit consent for the use of archival tissue samples: practical issues.
        J Med Ethics. 2004; 30: 561-564
        • Van Veen E.B.
        • Riegman P.H.
        • Dinjens W.N.
        • Lam K.H.
        • Oomen M.H.
        • Oosterhuis J.W.
        TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe.
        Eur J Cancer. 2006; 42: 2914-2923
        • Arnason V.
        Coding and consent: moral challenges of the database project in Iceland.
        Bioethics. 2004; 18: 27-49
        • Tutton R.
        • Kaye J.
        • Hoeyer K.
        Governing UK Biobank: the importance of ensuring public trust.
        Trends Biotechnol. 2004; 22: 284-285
        • Lin Z.
        • Altman R.B.
        • Owen A.B.
        Confidentiality in genome research.
        Science. 2008; 305: 441-442
      1. OECD. Draft guidelines for Human Biobanks and Genetic Research Databases; 2008.

      2. Dutch Act on the Medical Treatment Contract. <http://www.dutchdpanl/documenten/en_inf_subj_Confidentiality_Medical_Data.shtml> 2008 September 25 2008.

      3. Federation of Medical Scientific Societies. Code for Proper Use of Human Tissue. Code for Proper Secondary Use of Human Tissue in the Netherlands. Rotterdam: Federation of Medical Scientific Societies (FMWV); 2002.

        • Olsthoorn-Heim E.T.M.
        • Gevers J.K.M.
        Genetic research with stored human tissue; a coding procedure for optimal use of information and protection of privacy (comment).
        Ned Tijdschr Geneesk. 2004; 148 ([in Dutch]): 1263
        • Schmidt M.K.
        • van Leeuwen F.E.
        • Klaren H.M.
        • Tollenaar R.A.
        • ‘t Veer L.J.
        Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy.
        Ned Tijdschr Geneeskd. 2004; 148: 564-568
        • Schmidt M.K.
        • Tollenaar R.A.
        • van Leeuwen F.E.
        • van’t Veer L.J.
        Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2∗1100delC germline mutation.
        J Clin Oncol. 2007; 25: 64-69
      4. Schmidt MK, Vermeulen E, Tollenaar RAEM, Veer Lv’t, Leeuwen FEv. Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding. Submitted for publication.

        • Jack A.L.
        • Womack C.
        Why surgical patients do not donate tissue for commercial research: review of records.
        BMJ. 2003; 327: 262
        • Stegmayr B.
        • Asplund K.
        Informed consent for genetic research on blood stored for more than a decade: a population based study.
        BMJ. 2002; 325: 634-635
        • Wheeler J.
        • Agarwal M.
        • Sugden J.
        • Bladon M.
        • Quirke P.
        Experiences from the front line – routine consenting of surplus surgically removed tissue. Without investment by the NHS fully informed consent for all is not available.
        J Clin Pathol. 2007; 60: 351-354
        • Malone T.
        • Catalano P.J.
        • O’Dwyer P.J.
        • Giantonio B.
        High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience.
        J Natl Cancer Inst. 2002; 94: 769-771
        • Chen D.T.
        • Rosenstein D.L.
        • Muthappan P.
        • et al.
        Research with stored biological samples: what do research participants want?.
        Arch Intern Med. 2005; 165: 652-655
        • Hamajima N.
        • Tajima K.
        • Oya H.
        • et al.
        Patients’ views on residual blood use for research purposes.
        Jpn J Cancer Res. 1998; 89: 341-345
        • Hamilton S.
        • Hepper J.
        • Hanby A.
        • Hewison J.
        Consent gained from patients after breast surgery for the use of surplus tissue in research: an exploration.
        J Med Ethics. 2007; 33: 229-233
        • Kettis-Lindblad A.
        • Ring L.
        • Viberth E.
        • Hansson M.G.
        Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think?.
        Eur J Public Health. 2005;
        • McQuillan G.M.
        • Pan Q.
        • Porter K.S.
        Consent for genetic research in a general population: an update on the National Health and Nutrition Examination Survey experience.
        Genet Med. 2006; 8: 354-360
        • Start R.D.
        • Brown W.
        • Bryant R.J.
        • et al.
        Ownership and uses of human tissue: does the Nuffield bioethics report accord with opinion of surgical inpatients?.
        BMJ. 1996; 313: 1366-1368
        • Medical Research Council
        Public perceptions of the collection of human biological samples.
        Medical Research Council, 2000
        • Hock Y.L.
        • Balachandar C.
        • Dicken S.
        • Bayley C.
        • Ramaiah S.
        Patients’ perspective of pathology specimens. A prospective study.
        J Clin Pathol. 2005; 58: 891-893
        • Kohane I.S.
        • Masys D.R.
        • Altman R.B.
        The incidentalome. A threat to genomic medicine.
        JAMA. 2006; 296: 212-215
        • Wolf S.M.
        • Paradise J.
        • Caga-anan C.
        The law of incidental findings in human subjects research: establishing researchers’ duties.
        J Law Med Ethics. 2008; 36 (214): 361-383
        • Wolf S.M.
        • Lawrenz F.P.
        • Nelson C.A.
        • et al.
        Managing incidental findings in human subjects research: analysis and recommendations.
        J Law Med Ethics. 2008; 36 (211): 219-248
        • Lawrenz F.
        • Sobotka S.
        Empirical analysis of current approaches to incidental findings.
        J Law Med Ethics. 2008; 36 (211): 249-255
        • Van Ness B.
        Genomic research and incidental findings.
        J Law Med Ethics. 2008; 36 (212): 292-297
        • Junghans C.
        • Feder G.
        • Hemingway H.
        • Timmis A.
        • Jones M.
        Recruiting patients to medical research: double blind randomised trial of “opt-in” versus “opt-out” strategies.
        BMJ. 2005; 331: 940-944
        • Royal Dutch Academy of Sciences
        Foresight committee on multifactorial diseases in the genomics age. Multifactorial diseases in the genomics age.
        Koninklijke Nederlandse Akademie van Wetenschappen, Amsterdam2006
        • Cambon-Thomsen A.
        • Rial-Sebbag E.
        • Knoppers B.M.
        Trends in ethical and legal frameworks for the use of human biobanks.
        Eur Respir J. 2007; 30: 373-382
        • Hoshida Y.
        • Villanueva A.
        • Kobayashi M.
        • et al.
        Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
        New Engl J Med. 2008; 22: 22